169 related articles for article (PubMed ID: 26788192)
1. Association between factors associated with colorectal cancer and rectal aberrant crypt foci in humans.
Ezuka A; Sakai E; Kawana K; Nagase H; Kakuta Y; Uchiyama S; Ohkubo H; Higurashi T; Nonaka T; Endo H; Takahashi H; Nakajima A
Oncol Lett; 2015 Dec; 10(6):3689-3695. PubMed ID: 26788192
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.
Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
BMC Cancer; 2020 Aug; 20(1):770. PubMed ID: 32807113
[TBL] [Abstract][Full Text] [Related]
3. Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial.
Higurashi T; Hosono K; Endo H; Takahashi H; Iida H; Uchiyama T; Ezuka A; Uchiyama S; Yamada E; Ohkubo H; Sakai E; Maeda S; Morita S; Natsumeda Y; Nagase H; Nakajima A
BMC Cancer; 2012 Sep; 12():413. PubMed ID: 22992267
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
[TBL] [Abstract][Full Text] [Related]
5. Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
Ohkubo H; Takahashi H; Yamada E; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Taguri M; Nakajima A
Oncol Rep; 2012 May; 27(5):1475-80. PubMed ID: 22246586
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency of serrated aberrant crypt foci among smokers.
Anderson JC; Pleau DC; Rajan TV; Protiva P; Swede H; Brenner B; Heinen CD; Lambrecht RW; Rosenberg DW
Am J Gastroenterol; 2010 Jul; 105(7):1648-54. PubMed ID: 20234347
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
[TBL] [Abstract][Full Text] [Related]
9. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Smoking on the Number and Type of Rectal Aberrant Crypt Foci (ACF)-First Identifiable Precursors of Colorectal Cancer (CRC).
Kowalczyk M; Klepacki Ł; Zieliński E; Kurpiewski W; Zinkiewicz K; Dyśko Ł; Pesta W
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375262
[TBL] [Abstract][Full Text] [Related]
11. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
Kowalczyk M; Orłowski M; Siermontowski P; Mucha D; Zinkiewicz K; Kurpiewski W; Zieliński E; Kowalczyk I; Pedrycz A
BMC Cancer; 2018 Feb; 18(1):213. PubMed ID: 29466973
[TBL] [Abstract][Full Text] [Related]
13. A multicenter study of prevalence and risk factors for aberrant crypt foci.
Mutch MG; Schoen RE; Fleshman JW; Rall CJ; Dry S; Seligson D; Charabaty A; Chia D; Umar A; Viner J; Hawk E; Pinsky PF
Clin Gastroenterol Hepatol; 2009 May; 7(5):568-74. PubMed ID: 19418605
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the plasma level of insulin-like growth factor-1 with the number of aberrant crypt foci in male individuals.
Takahashi H; Takayama T; Hosono K; Yoneda K; Endo H; Nozaki Y; Fujita K; Yoneda M; Inamori M; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakagama H; Nakajima A
Mol Med Rep; 2009; 2(3):339-43. PubMed ID: 21475834
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci.
Kowalczyk M; Sigorski D; Dyśko Ł; Zieliński E; Zupanovich Lucka D; Klepacki Ł
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556972
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study.
Takahashi H; Hosono K; Uchiyama T; Sugiyama M; Sakai E; Endo H; Maeda S; Schaefer KL; Nakagama H; Nakajima A
PPAR Res; 2010; 2010():. PubMed ID: 20814432
[TBL] [Abstract][Full Text] [Related]
17. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates the formation of aberrant crypt foci, mucin-depleted foci, and cell proliferation on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in Wistar rats.
Mohania D; Kansal VK; Kruzliak P; Kumari A
Rejuvenation Res; 2014 Aug; 17(4):325-33. PubMed ID: 24524423
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.
Rudolph RE; Dominitz JA; Lampe JW; Levy L; Qu P; Li SS; Lampe PD; Bronner MP; Potter JD
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):605-8. PubMed ID: 15767337
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial.
Higurashi T; Ashikari K; Tamura S; Saigusa Y; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Kessoku T; Hosono K; Yoneda M; Nakajima A
Cancer Prev Res (Phila); 2022 Oct; 15(10):661-668. PubMed ID: 36083855
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer.
Greenspan EJ; Cyr JL; Pleau DC; Levine J; Rajan TV; Rosenberg DW; Heinen CD
Carcinogenesis; 2007 Apr; 28(4):769-76. PubMed ID: 17088260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
